Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-15

Clinical Trial Update: Uganda PrEP and Harm Reduction Evaluation [NA]

View source ↗

Summary

Study NCT05040308, Uganda PrEP and Harm Reduction Evaluation, is currently active but not recruiting, focusing on HIV-1 infection. This status update confirms t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Washington | Conditions: HIV-1-infection | NA | Status: ACTIVE_NOT_RECRUITING